Phase 2 human trials for Bharat Biotech vaccine to begin in September

▴ Phase 2 human trials for Bharat Biotech vaccine to begin in September
A brief roundup of all the vaccines under development

As India races against time to bring a safe and efficient anti-coronavirus vaccine made indigenously within the country, phase 1 of the human trials in most centres chosen for COVAXIN trials have concluded, India Today TV has learnt. The centres are now bracing for recruitment of candidates for phase 2 human trials, which are scheduled to begin in the first week of September.

Except for AIIMS Delhi - one of the 12 centres for the Bharat Biotech vaccine - where phase 1 trials are still underway, most of the other 11 centres have completed the process. AIIMS Delhi has only recruited 16 candidates for the vaccine human trials phase 1.

Initially, AIIMS Delhi was supposed to recruit 100 candidates for the vaccine trials. The total candidate recruitment for phase 1 Bharat Biotech trials in 12 centres is 375.

Sources at the AIIMS centre said that the phase 2 human trials will likely begin in the first week of September. The findings of phase 1 trials will be submitted soon. Preliminary results of Phase 1 clinical trials showed that Covaxin is safe, sources associated with the Phase1 trial have confirmed.

Meanwhile, in Maharashtra's trial centre in Nagpur phase 1 trials have been completed as 55 healthy participants were vaccinated with the first dose of vaccine, the clinical lead investigator informed India Today. "After the first dosing, two patients reported some fever-related symptoms. However, they got better after a few hours of monitoring without any medical intervention," said a source at the centre.

The second round of dosing was also done for seven candidates, two days ago. 13 more candidates were given second dosage of COVAXIN on Thursday. The centre in Nagpur submitted initial results of phase 1 human trials to Bharat Biotech, sources said.

Similarly, phase 1 trials at the Jeevan Rekha Hospital in Belgaum, Karnataka have been completed. Only four people have been vaccinated at the centre. After completion of 28 days, data of the clinical trials will be submitted to Bharat Biotech, said a source from the centre. Phase 2 trial recruitment will begin in the first week of September. These findings will be based on a monitoring done for 28 days after the Phase 1.

Three vaccine candidates are currently in different phases of human trials.

Meanwhile, the Serum Institute of India (SII) has been granted regulatory approval to conduct phase 2 and 3 trials in India Covishield, a vaccine created by the University of Oxford and AstraZeneca. SII plans to start human trials in less than two weeks, India Today has learnt.

20 different sites have been chosen along with hospitals across the country, covering five different regions that are also Covid-19 hotspots. SII will conduct trials across 11-12 hospitals in partnership with ICMR. Currently, the recruitment process for at least 1,000 candidates is underway at the trial sites.

Phase 1 trials of ZyCOV-D the vaccine being made by Zydus Cadila have been completed. The company has reported that the Phase 2 trials have commenced, and the trials will be conducted on 1,000 healthy participants in Ahmedabad.

"An independent Data Safety Monitoring Board (DSMB) endorsed the seven-day safety of the vaccine in all the Phase I participants," a statement by the company said.

Story Courtesy - 

Tags : #CovaxinNews #ZyCov-D #SerumInstitute #ZydusCadila #BharatBiotech #JeevanRekhaHospitalBelgaum #IndiaVaccineNewsLatestAug14 #IndiaVaccineNewsUpdatesAug14 #Covidshield

About the Author

Team Medicircle

Related Stories

Loading Please wait...

Trending Now

Dr. Rohan Palshetkar shares his invaluable insights about the Maternal Mortality Rate causes and improvements in India April 29, 2021
It is important to adopt a non-judgmental attitude towards any teenage girl seeking contraceptive advise suggests Dr. Teena Trivedi, Obstetrician and GynecologistApril 16, 2021
80% of the diseases are psychosomatic which means they have roots in the mind and this is where homeopathy steps in - It resolves physical ailments by finding the cause in the mind – Dr. Sanket Dhuri, Consultant Homeopath April 14, 2021
A futuristic Vision of a Healthcare Entrepreneur: Shyatto Raha, CEO, and Founder of MyHealthcareApril 12, 2021
Saher Mehdi, Founder and Chief Scientist at wellOwise talks about aspects making healthcare more equitable and reachableApril 10, 2021
Wide variety of therapies to address autism in children explained by Dr. Shilpa Jasubhai, Clinical PsychologistApril 09, 2021
Allopathic and Homeopathic medicines should not be taken together says Dr. Sunil Mehra, Homeopath ConsultantApril 08, 2021
The charm of homeopathic medicine is that it can be taken with conventional medicines – Dr. Shruthi Shridhar, Consulting Homeopath April 08, 2021
Dissociative Identity Disorder and associated concepts explained by Dr. Vinod Kumar, Psychiatrist and Head of Mpower - The Centre (Bangalore) April 07, 2021
Dissociative Identity Disorder explained by Dr. Shilpa Jasubhai, Clinical PsychologistApril 05, 2021
Sehat Ki Baat, Karishma Ke Saath- Episode 6 Healthy Diet For Boosting Metabolism Which Can Help Thyroid Patients April 03, 2021
Significant Pointers on Kidney Health by Dr. Santosh Waigankar, Consultant Urooncologist and Robotic Surgeon at Kokilaben Dhirubhai Ambani HospitalApril 01, 2021
Dr. Vaishal Kenia, Ophthalmologist Talks About the Different Possibilities Available for the Treatment of Glaucoma Depending Upon Their Type and SeverityMarch 30, 2021
No Definitive Role of Diet in Treatment of Lymphedema but Intake of Calories, Salt and Long Chain Fatty Acids should be controlled says Dr. Ramani CVMarch 30, 2021
Dr. Kiran Chandra Patro, Senior Nephrologist Talks About Dialysis as the Temporary Process and Not a Permanent Cure for the Patients of Renal DysfunctionMarch 30, 2021
Two out of three new chronic kidney disease patients are found to have diabetes or hypertension informs Dr. Sreeharsha HarinathaMarch 30, 2021
Glaucoma Treatment: Medications or Surgery? A valuable piece of advice from Dr. Pranay Kapdia, Chairman and Medical Director of Kapadia Eye CareMarch 25, 2021
Dr. Shraddha Satav, Consultant Ophthalmologist Recommends that Everybody After 40, Should Go for the Complete Eye Checkup at Regular IntervalMarch 25, 2021
Childhood Obesity is not a Disease but a Condition which can be very well ManagedMarch 19, 2021
World Sleep Day - 19 th March 2021- Know More About Healthy Sleep As Per The Guidelines by The World Sleep Society March 19, 2021